Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan 28;38(1):5.
doi: 10.1186/s40902-016-0051-7. eCollection 2016 Dec.

A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment

Hyun-Suk Kim  1 , Pil-Young Yun  1 , Young-Kyun Kim  1   2
Affiliations

A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment

Hyun-Suk Kim et al. Maxillofac Plast Reconstr Surg. .

Abstract

Background: This study clinically evaluated the effect of botulinum toxin type A (BTX-A) in the temporomandibular disorder (TMD) treatment using Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD).

Methods: A total of 21 TMD patients were recruited to be treated with BTX-A injections on the bilateral masseter and temporalis muscles and were followed up by an oral and maxillofacial surgeon highly experienced in the TMD treatment. For each patient, diagnostic data gathering were conducted according to the RDC/TMD. Characteristic pain intensity, disability points, chronic pain grade, depression index, and grade of nonspecific physical symptoms were evaluated. Wilcoxon signed-rank test was applied for statistical analysis.

Results: The results showed that more than half of the participants (85.7 %) had parafunctional oral habits such as bruxism or clenching. In comparison between pre- and post-treatment results, graded pain score, characteristic pain intensity, disability points, chronic pain grade, and grade of nonspecific physical symptoms showed statistically significant differences after the BTX-A injection therapy (p < 0.05). Most patients experienced collective decrease in clinical manifestations of TMD including pain relief and improved masticatory functions after the treatment.

Conclusions: Within the limitation of our study, BTX-A injections in masticatory musculatures of TMD patients could be considered as a useful option for controlling complex TMD and helping its associated symptoms.

Keywords: Botulinum toxin type A; Research diagnostic criteria for temporomandibular disorder; Temporomandibular disorder.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fricton JR, Kroening RJ, Hathaway K. TMJ and craniofacial pain: diagnosis and management. 1. St. Louis, Tokyo: Ishiyaku EuroAmerica, Inc.; 1988. pp. 27–37.
    1. Guarda-Nardini L, Manfredini D, Salamone M, et al. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio. 2008;26:126–35. - PubMed
    1. Bjornland T, Gjaerum AA, Moystad O. Osteoarthritis of the temporomandibular joint: an evaluation of the effects and complications of corticosteroid injections compared with injection with sodium hyaluronate. J Oral Rehabil. 2007;34:583–9. doi: 10.1111/j.1365-2842.2007.01759.x. - DOI - PubMed
    1. Chung JW, Chung SC (2002) Research Diagnostic Criteria for Temporomandibular Disorders RDC/TMD. www.rdc-tmdinternational.org.
    1. Shibuya Y, Takeuchi J, Ikehata N, et al. A clinical study of temporomandibular joint disorders—an analysis based on the Japanese subtype classification. Kobe J Med Sci. 2007;53:63–70. - PubMed

LinkOut - more resources